News
Latest news
ADARx Raises $46 Million as Lead Product Enters the Clinic

ADARx Pharmaceuticals

January 20 2023
CG Oncology Raises $120 Million in Oversubscribed Series E Financing to Advance Clinical-Stage Urologic Oncology Pipeline

CG Oncology

November 15 2022
ADARx Raises $75 Million to Advance Growing Pipeline

ADARx Pharmaceuticals

September 08 2021
ArriVent Launches with Up To $150M in Series A Financing and Strategic Licensing Agreement for Clinical-Stage Oncology Asset

Arrivent Biopharma

June 30 2021

Get In Touch

Contact Us